TrialHeart (British Cardiac Society)2012

Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation.

Anuraag R Kansal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.